gnr-055
Gene therapyexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
1
Phase 4
0
Earliest trial started Feb 28, 2020 (NCT04539340)
Timeline
Indications
Mechanism of action
- Iduronate 2-sulfataseSupplementation
IDS supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06475404 | Phase 1 | Apr 6, 2023 | AO GENERIUM |
| NCT05208281 | Phase 2/Phase 3 (Phase 3) | Nov 30, 2021 | AO GENERIUM |
| NCT04539340 | Phase 1 | Feb 28, 2020 | AO GENERIUM |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| AO GENERIUM | For profit | 3 | 3 | 2 | 2020 |
1 organizations
Page 1 / 1